AtaiBeckley Inc. SEC EDGAR Filings (CIK 0002081043)

SEC EDGAR filings, ownership reports, and insider transactions for AtaiBeckley Inc..

Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
C/O Atai Life Sciences Us, Inc., C/O Industrious Nyc, 250 West 34 Th St., New York, NY, 10119
Top holdings (Schedule 13D)
CMPS
State of incorporation
DE
Fiscal year end
31 December
Former names
atai Life Sciences Luxembourg S.A. (to 31 Dec 2025)
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
AtaiBeckley Inc. has filed 26 SEC EDGAR filings since 13 Aug 2025

Latest Filings

Recent SEC filings for AtaiBeckley Inc. including 8-K, 10-K, S-8 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 06 Mar 2026 06 Mar 2026 001-43037
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K 10-K 06 Mar 2026 31 Dec 2025 001-43037
S-8 Open S-8 document | Open XBRL data View SEC filing for S-8 S-8 06 Mar 2026 333-294123
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 06 Mar 2026 06 Mar 2026 001-43037
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 26 Feb 2026 26 Feb 2026 001-43037
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 19 Feb 2026 15 Feb 2026 001-43037
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 17 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 03 Feb 2026 30 Jan 2026
4 Open 4 document View SEC filing for 4 FORM 4 03 Feb 2026 30 Jan 2026
4 Open 4 document View SEC filing for 4 FORM 4 03 Feb 2026 30 Jan 2026
4 Open 4 document View SEC filing for 4 FORM 4 03 Feb 2026 30 Jan 2026
4 Open 4 document View SEC filing for 4 FORM 4 03 Feb 2026 30 Jan 2026
4 Open 4 document View SEC filing for 4 FORM 4 03 Feb 2026 30 Jan 2026
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 08 Jan 2026 06 Jan 2026 001-43037
4 Open 4 document View SEC filing for 4 FORM 4 06 Jan 2026 02 Jan 2026
8-K12B Open 8-K12B document | Open XBRL data View SEC filing for 8-K12B 8-K12B 31 Dec 2025 30 Dec 2025 001-43037
S-8 POS Open S-8 POS document View SEC filing for S-8 POS S-8 POS 31 Dec 2025 333-257482-01
S-4MEF Open S-4MEF document | Open XBRL data View SEC filing for S-4MEF S-4MEF 29 Dec 2025 333-292459
424B3 Open 424B3 document View SEC filing for 424B3 424B3 27 Oct 2025 333-290446
POS EX Open POS EX document View SEC filing for POS EX POS EX 27 Oct 2025 333-290446
EFFECT Open EFFECT document View SEC filing for EFFECT 24 Sep 2025 333-290446
424B3 Open 424B3 document View SEC filing for 424B3 424B3 24 Sep 2025 333-290446
CORRESP Open CORRESP document View SEC filing for CORRESP 22 Sep 2025
S-4 Open S-4 document | Open XBRL data View SEC filing for S-4 S-4 22 Sep 2025 333-290446
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 19 Aug 2025 377-08326
DRS Open DRS document View SEC filing for DRS 13 Aug 2025 377-08326

About this filer

AtaiBeckley Inc. files with the SEC under CIK 0002081043. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages